Results 101 to 110 of about 268,751 (268)

Acalabrutinib for mantle cell lymphoma.

open access: yesBlood, 2019
Mantle cell lymphoma (MCL) is a unique type of non-Hodgkin lymphoma characterized by the overexpression of cyclin D1. MCL patients typically live for years but experience multiple relapses.
T. Witzig, D. Inwards
semanticscholar   +1 more source

p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32) [PDF]

open access: bronze, 1995
DC Louie   +6 more
openalex   +1 more source

Relapsed Mantle Cell Lymphoma Presenting as “Sister Mary Joseph Nodule”

open access: yesCase Reports in Medicine, 2010
The finding of umbilical metastasis has historically been called a “Sister Mary Joseph Nodule”. A few case reports of lymphoma presenting in this manner have been documented. We report a case of relapsed mantle cell lymphoma (MCL) presenting as a Sister
Jennifer E. Vaughn, Ajay K. Gopal
doaj   +1 more source

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma.

open access: yesNew England Journal of Medicine, 2013
Michael L. Wang   +30 more
semanticscholar   +1 more source

Chimeric antigen receptor T-cell therapy for aggressive B-cell lymphomas

open access: yesFrontiers in Oncology
Chimeric antigen receptor (CAR) T-cell therapy is a revolutionary approach in the treatment of lymphoma. This review article provides an overview of the four FDA-approved CAR T-cell products for aggressive B-cell lymphoma, including diffuse large B-cell ...
Bei Hu   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy